Nicholas Investment Partners’s Array Biopharma Inc ARRY Stock Holding History

Nicholas Investment Partners’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-176,570	Closed	-$8.18M	–	239
2019 Q2	$8.18M	Sell	176,570 -4,537	-3%	-$127K	0.75%	35
2019 Q1	$4.42M	Buy	181,107 +129	+0.1%	+$2.69K	0.39%	88
2018 Q4	$2.58M	Sell	180,978 -205	-0.1%	-$3.11K	0.28%	134
2018 Q3	$2.75M	Sell	181,183 -2,652	-1%	-$40.6K	0.22%	166
2018 Q2	$3.08M	Buy	183,835 +21,828	+13%	+$347K	0.22%	152
2018 Q1	$2.64M	Sell	162,007 -65,395	-29%	-$1.05M	0.19%	167
2017 Q4	$2.91M	Sell	227,402 -49,740	-18%	-$566K	0.19%	168
2017 Q3	$3.41M	Buy	+277,142	New	+$2.57M	0.24%	149

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Nicholas Investment Partners's ARRY Position: Q3 2019 in Review

Nicholas Investment Partners sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 176,570 shares — an estimated $8.18M sold.

Nicholas Investment Partners first reported a position in ARRY in Q3 2017 and held it in 8 quarters. The position peaked at $8.18M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Nicholas Investment Partners reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Nicholas Investment Partners sold 176,570 Array Biopharma Inc shares in Q3 2019, an estimated $8.18M.
Nicholas Investment Partners first reported a position in Array Biopharma Inc in Q3 2017 and held it in 8 quarters.
Nicholas Investment Partners's Array Biopharma Inc position peaked at $8.18M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Nicholas Investment Partners's 13F filing for Q3 2019, filed 13 Nov 2019.